Efficacy and Safety of TAK-385 in the Treatment of Uterine Fibroids

NCT01452659 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

216

Enrollment

INDUSTRY

Sponsor class

Conditions

Uterine Fibroids

Interventions

DRUG: TAK-385
DRUG: TAK-385
DRUG: TAK-385
DRUG: Placebo

Sponsor

Takeda